Dilip Shanghvi, Chairman and Managing Director of Sun Pharma, said, "We are pleased with the successful completion of Taro merger process. This milestone marks a significant step forward for both ...

Artlist, a creative technology company that provides a vast catalog of royalty-free digital assets to empower brands and content creators worldwide, today announced its latest offering ? an in-product ...

What is the outlook of the Altimmune stock price after the company announced encouraging Pemvidutide tests? We explain what ...

Good morning, and Happy Monday! Here’s everything you need (and some stuff you don’t need) to know before the ASX opens today ...

Viking (VKTX) made headlines in February when its stock rose ... Another dark horse in the race to bring an oral weight-loss ...

Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO), which already have blockbusters with their weight loss drugs Zepbound ...

Raymond James raised the price target for the Viking Therapeutics Inc (NASDAQ:VKTX) stock from “an Outperform” to “a Strong buy”. The rating was released on May 16, 2024, according to finviz. We ...

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $50.43, marking a -0.41% move from the previous day.

Local shares have staged something of a recovery this week, but it’s been hard yakka for the bulk of the market thanks to the ...

Rezdiffra, the first drug approved to treat MASH, was approved this year. Recent advancements offer new hope to patients.